Baldicantos, Baby Boy .

HRN: 24-25-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
AMPICILLIN 250MG (VIAL)
12/23/2023
12/29/2023
IV
150mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: